Inconsistent state immunization laws complicate pharmacy operations and limit patient access.
|Articles|August 24, 2022
Daily OTC Pearl: Non-Aspirin
Author(s)Saro Arakelians, PharmD
Acetaminophen helps to reduce fevers and treat headaches, pains, and menstrual cramps.
Advertisement
OTC/Lifestyle Pearl of the Day: Non-Aspirin
Indication: Acetaminophen helps to reduce fevers and treat headaches, pains, and menstrual cramps.
Insight:
- Take 2 tablets every 4 to 6 hours.
- Do not take more than 8 in 24 hours period.
- Store at room temperature.
- Keep away from children.
- If pregnant, consult with health care professional first.
Advertisement
Related to this article
Pharmacists can strengthen opioid safety through individualized counseling, overdose prevention, and coordinated follow-up that keeps patients involved in treatment decisions.
OCEANIC-STROKE supports a potential additional antithrombotic approach for select patients after noncardioembolic stroke or high-risk TIA.
Nicole Albanese, PharmD, explains how a structured testing schedule and simple notes help patients bring useful glucose data to their care team.
Garlic has a long history in traditional medicine, but evidence for its benefits varies by preparation, and patients taking medications that increase bleeding risk should use it with caution.
About 89% of Americans live within 5 miles of a pharmacy, but proximity says little about whether they can afford their medications or get real counseling.
The costs to patients, their families, their workplaces, and their communities go well beyond dollars and cents.
Getting patients vaccinated matters more than which COVID-19 vaccine they receive, says Jodi Longueil, PharmD.
Advertisement
Advertisement
Trending on Pharmacy Times
1
mRNA vs Protein-Based COVID-19 Vaccines: What Pharmacists Can Tell Patients
2
Asundexian Receives FDA Approval, Becomes First FXIa Inhibitor for Secondary Stroke Risk Reduction
3
FDA Reportedly Shelves Commissioner's National Priority Voucher Program
4
Inside the OCEANIC-STROKE Trial and What Asundexian Means for the Future of Stroke Prevention
5